National Gallbladder and Bile Duct Cancer Awareness MonthThis month, MyGeneticsTree acknowledges individuals and family members with a history of Gallbladder and Bile Duct Cancer
National Colorectal and Kidney Cancer Awareness MonthThis month, MyGeneticsTree acknowledges individuals and family members with a history of Colorectal and Kidney Cancer
National Brain Cancer Awareness MonthThis month, MyGeneticsTree acknowledges individuals and family members with a history of Brain Cancer
National Sarcoma Awareness MonthThis month, MyGeneticsTree acknowledges individuals and family members with a history of Sarcoma Awareness
National Leukemia/Lymphoma, Ovarian and Prostate Cancer Awareness MonthThis month, MyGeneticsTree acknowledges individuals and family members with a history of Leukemia/Lymphoma, Ovarian and Prostate Cancer
National Breast Cancer Awareness MonthThis month, MyGeneticsTree acknowledges individuals and family members with a history of Breast Cancer
National Pancreatic and Stomach Cancer Awareness MonthThis month, MyGeneticsTree acknowledges individuals and family members with a history of Pancreatic and Stomach Cancer
Knowledge is Power
MyGeneticsTree: A Digital Tool for Identifying Patients at Risk for Hereditary Cancer
While the majority of cancer is sporadic and occurs by chance, approximately 5-10% is hereditary and occurs because an individual was born with a harmful change in a gene that increased their risk to develop cancer1. It is estimated that approximately 5-10% of breast cancer2, up to 10% of colorectal cancer3, 5-10% of prostate cancer4, and up to 24% of ovarian cancer5 is due to a harmful change in a gene associated with hereditary cancer. Other types of cancer may also be hereditary.
MyGeneticsTree is an automated and secure digital tool that helps healthcare providers identify patients eligible for hereditary cancer genetic testing. It is simple enough that patients can complete the questionnaire on their own (at home) in advance of their appointment, or while in the waiting room. MyGeneticsTree is computer, tablet, and mobile-friendly.
Benefits of using MyGeneticsTree
MyGeneticsTree can be used to analyze a patient’s personal history & family history to determine if they meet national criteria for hereditary cancer genetic testing.
Individuals with a personal and/or family history of one of more of the following may be at risk for hereditary cancer:
- Cancer at a young age (under 50)
- Rare cancers at any age (such as male breast cancer, pancreatic, ovarian cancer)
- More than one type of cancer in the same individual (also referred to as multiple primary cancers)
- 10 or more colon polyps
- A known genetic alteration in the family
- Multiple cases of cancers on one side of the family spanning multiple generations
- An individual of Ashkenazi Jewish descent with breast, prostate, ovarian, or pancreatic cancer at any age
MyGeneticsTree automates the process of identifying patients that meet criteria and focuses on patients at risk for hereditary cancer. Upon patient completion of the assessment, you will receive a personalized report identifying hereditary cancer syndromes for which your patient qualifies for testing. It also recommends genes you may consider ordering based upon the patient's history and medical neccesity. For testing deemed medically necessary, test options are available through BioReference Labs, GenPath, or GeneDx, Inc. (all OPKO Health companies).
Hereditary cancer testing options available include:
- Breast and Gynecological Cancer Panels
- Colorectal Cancer Panels
- Panels for Multiple Cancer Types
- Tumor Specific Panels
For more information on hereditary cancers testing options available through BioReference Laboratories, please visit the BioReference Laboratories website.
What MyGeneticsTree Offers your Practice
MyGeneticsTree offers practices a full program for identifying patients who qualify for hereditary cancer genetic testing.
- Stratifies patient population for hereditary cancer risk
- Identifies patients who meet criteria for testing and provides guidance on most appropriate testing options
- Identifies women at increased risk for breast cancer who may benefit from increased surveillance/enhanced imaging
- Results summaries for both providers and patients
- Provides a head start on paperwork and documentation
MyGeneticsTree can also provide your patients with access to both pre- and post-test genetic counseling services through our collaboration with MyGeneTeam. Click here to learn more about the genetic counseling services available through MyGeneTeam.
Available Customizations of MyGeneticsTree
Tailor MyGeneticsTree to meet the needs of your clinic and integrate seamlessly into your practice. Custom options available include a custom URL unique to your practice (additional cost), custom provider lists, specifications that fit into your practice workflow, and more.
Breast Cancer Risk Assessment
MyGeneticsTree offers a personalized breast cancer risk estimate, specific to female patients only. Using the validated Tyrer-Cuzick calculation, MyGeneticsTree estimates a woman’s 10-year and lifetime breast cancer risk.
MyGeneticsTree produces a personalized clinical summary, testing options, a pedigree and more.
Contact your sales representative to receive a demo and introduction into MyGeneticsTree.
Not a current client? Contact us at firstname.lastname@example.org to sign up.
1 National Cancer Institute. Genetic Testing for Hereditary Cancer Syndromes – What is genetic testing?
2 USPSTF. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer
4American Cancer Society. Prostate Cancer Causes, Risk Factors, and Prevention